首页 | 本学科首页   官方微博 | 高级检索  
检索        

大黄酸在大鼠和比格犬体内的吸收动力学研究
引用本文:张锦雯,孙建国,王广基,谢海棠,顾轶,贾元威,郑超男,黎磊石,刘志红,章海涛.大黄酸在大鼠和比格犬体内的吸收动力学研究[J].中国临床药理学与治疗学,2010,15(5):511-518.
作者姓名:张锦雯  孙建国  王广基  谢海棠  顾轶  贾元威  郑超男  黎磊石  刘志红  章海涛
作者单位:1. 中国药科大学药物代谢动力学国家重点实验室,南京,210038,江苏
2. 中国药科大学药物代谢动力学国家重点实验室,南京,210038,江苏;皖南医学院弋矶山医院安徽省药物临床评价中心,芜湖,241001,安徽
3. 南京军区南京总医院解放军肾脏病研究所,南京,210002,江苏
基金项目:科技部"十五"重大专项(863),"一类抗糖尿病肾病治疗新药大黄酸研究"项目,国家"863"计划基金资助项目,重大新药创制项目 
摘    要:目的:研究中药大黄的活性蒽醌单体大黄酸(rhein)在SD大鼠和Beagle犬体内的吸收动力学特征,为临床的进一步研究提供基础参数和依据。方法:采用HPLC-荧光检测法分别测定SD大鼠和Beagle犬在灌胃及静脉注射两种给药途径下单次给予不同剂量的大黄酸药物后,两种动物血浆样品中的大黄酸经时曲线过程并计算相应的药代动力学参数及绝对生物利用度。结果:SD大鼠灌胃及静脉注射高、中、低剂量大黄酸后,AUC与剂量间呈一定的线性关系(r〉0.99),灌胃及静脉注射3个剂量下的半衰期结果相似。在上述研究范围内大黄酸在大鼠体内的药代动力学行为近似是线性的。用面积法,算得高、中、低3个剂量下大黄酸在大鼠体内的绝对生物利用度分别为16.4%、23.8%、19.4%。对6只Beagle犬进行随机交叉试验,静脉注射大黄酸真溶液(0.4mg/kg)和灌胃大黄酸混悬液(20mg/kg),算得静注及灌胃后药物的消除半衰期分别为(1.77±0.93)、(3.25±0.80)h,Beagle犬体内的绝对生物利用度为(49.7±7.4)%。对Beagle犬组(6只)和SD大鼠灌胃3剂量组(18只)各只动物生物利用度进行方差分析,结果显示差异具有统计学意义(P〈0.01)。结论:大黄酸在不同动物间吸收存在一定的种属差异,吸收程度在Bea-gle犬体内略高于在大鼠体内。

关 键 词:大黄酸  SD大鼠  Beagle犬  体内吸收  血浆药物浓度  药代动力学HPLC-荧光检测法

Pharmacokinetic comparision in absorption of Rhein in SD rats and Beagle dogs
ZHANG Jin-wen,SUN Jian-guo,WANG Guang-ji,XIE Hai-tang,GU Yi,JIA Yuan-wei,ZHENG Chao-nan,LI Lei-shi,LIU Zhi-hong,ZHANG Hai-tao.Pharmacokinetic comparision in absorption of Rhein in SD rats and Beagle dogs[J].Chinese Journal of Clinical Pharmacology and Therapeutics,2010,15(5):511-518.
Authors:ZHANG Jin-wen  SUN Jian-guo  WANG Guang-ji  XIE Hai-tang  GU Yi  JIA Yuan-wei  ZHENG Chao-nan  LI Lei-shi  LIU Zhi-hong  ZHANG Hai-tao
Institution:1Key Laboratory of Drug Metabolism and Pharmacokinetics,China Pharmaceutical University,Nanjing 210038,Jiangsu,China; 2Institute of Clinical Pharmacology of Yijishan Hospital,Wuhu 241001,Anhui,China; 3Research Institute of Nephrology,Nanjing Hospital,Nanjing 210002,Jiangsu,China)
Abstract:AIM:An in vivo study was conducted to evaluate the pharmacokinetic profile of Rhein (an anthraquinone derivatives isolated from chinese rhubarab) in plasma of SD rats and Beagle dogs. METHODS:Using a rapid and sensitive HPLC-Fluorescence mothod to determine the plasma concentration of rhein after a single i.v. and i.g. administration to SD rats and Beagle dogs at different dosages. A representative plasma concentration vs time profile was illustrated,and the PK parameters and absolute bioavailability were calculated based on these results. RESULTS:After a single i.g. administration and a single i.v. injection of rhein at high,middle and low dosages to rats,there was a good linear relationship between the AUC and dosage (r〉0.99). The estimated half life of rhein had some similarities in three different dosage of i.g. administration and i.v. injection. These indicated a linearity pharmacokinetic behavior of rhein in the studied dosage range. The oral bioavailability of rhein in SD rats of high、middle and low dosages were 16.4%,23.8% and 19.4%,respectively. The pharmacokinetic profiles of rhein to six Beagle dogs show that:after a single i.v. administration of 0.4 mg/kg,and i.g. administration of 20 mg/kg,the estimated half life of rhein were (1.77±0.93) h and (3.25±0.80) h,respectively. However,the oral absolute bioavailability of rhein in Beagle dogs was (49.7±7.4)%. Analysis the subject bioavailability data of each Beagle dog (n=6) and each rat in three oral dosage groups (n=18),showed a statistically significant difference (P〈0.01) between this two groups. CONCLUSION:There are some species differences between dogs and rats in absorption behavior.The absorption in dogs is higher than in rats.
Keywords:Rhein  SD rat  Beagle dog  Absorption in vivo  Plasma concentration  Pharmacokinetics  HPLC-Fluorescence
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号